Koers Sevion Therapeutics Inc OTC Bulletin Board
Aandelen
US81834Q1040
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 2,81 mln. 2,59 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | - | Nettowinst (verlies) 2024 * | - | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,1
x | K/w-verhouding 2024 * |
-0,11
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 95,63% |
Recentste transcriptie over Sevion Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 01-11-20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 08-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 01-05-14 |
Alan Walts
BRD | Director/Board Member | 64 | 01-04-21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,83% | 118 mld. | |
+10,80% | 106 mld. | |
-10,84% | 23,4 mld. | |
-1,69% | 22,1 mld. | |
-10,23% | 18,34 mld. | |
-41,92% | 16,59 mld. | |
-15,11% | 15,97 mld. | |
+6,62% | 14,03 mld. | |
+17,53% | 11,67 mld. |
- Beurs
- Aandelen
- Koers ELOX
- Koers